Products Affected - Description

• • Sodium Phosphate injection, Fresenius Kabi, 3 mmol/mL, 15 mL vial, 25 count, NDC 63323-0881-16
  • Sodium Phosphate injection, Fresenius Kabi, 3 mmol/mL, 5 mL vial, 25 count, NDC 63323-0884-06
  • Sodium Phosphate injection, Fresenius Kabi, 3 mmol/mL, 50 mL vial, 25 count, NDC 63323-0886-56
  • Sodium Phosphate injection, Pfizer, 3 mmol/mL, 15 mL vial, 25 count, NDC 00409-7391-72

Reason for the Shortage

• • Fresenius Kabi has sodium phosphate injection on shortage due to increased demand.
  • Pfizer has sodium phosphate injection on shortage due to manufacturing delays.

Available Products

• • There is insufficient supply for usual ordering

• • Pfizer has sodium phosphate 3 mmol/mL 15 mL vials only available for emergency orders via direct orders.
  • Fresenius Kabi has sodium phosphate 3 mmol/mL 5 mL and 50 mL vials on back order and the company cannot estimate a release date. The 15 mL vials are on back order and the company estimates a release date of early-April 2024.